flutiform 125 microgram/5 microgram per metered dose pressurised inhalation, suspension
mundipharma pharmaceuticals limited - fluticasone propionate; formoterol fumarate dihydrate - pressurised inhalation, suspension - 125 µg/5 microgram(s)/dose - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; formoterol and fluticasone
flutiform 250 microgram/10 microgram per metered dose pressurised inhalation, suspension
mundipharma pharmaceuticals limited - fluticasone propionate; formoterol fumarate dihydrate - pressurised inhalation, suspension - 250 µg/10 microgram(s)/dose - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; formoterol and fluticasone
flutiform 50 microgram/5 microgram per metered dose pressurised inhalation, suspension
mundipharma pharmaceuticals limited - fluticasone propionate; formoterol fumarate dihydrate - pressurised inhalation, suspension - 50 µg/5 microgram(s)/dose - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; formoterol and fluticasone
flutiform k-haler 125 microgram/5 microgram per actuation pressurised inhalation, suspension
mundipharma pharmaceuticals limited - fluticasone propionate; formoterol fumarate dihydrate - pressurised inhalation, suspension - 125 µg/5 µg/actuation - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; formoterol and fluticasone
flutiform k-haler 50 microgram/5 microgram per actuation pressurised inhalation, suspension
mundipharma pharmaceuticals limited - fluticasone propionate; formoterol fumarate dihydrate - pressurised inhalation, suspension - 50 µg/5 µg/actuation - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; formoterol and fluticasone
atectura breezhaler
novartis europharm limited - indacaterol acetate, mometasone furoate - asthma - drugs for obstructive airway diseases, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
flutiform® pressurised inhalation suspension 50 microgram5 microgram per actuation
mundipharma pharmaceuticals pte. ltd. - fluticasone propionate; formoterol fumarate dihydrate - aerosol, metered - 50 mcg/actuation - fluticasone propionate 50 mcg/actuation; formoterol fumarate dihydrate 5 mcg/actuation
flutiform® pressurised inhalation suspension 125 microgram5 microgram per actuation
mundipharma pharmaceuticals pte. ltd. - fluticasone propionate; formoterol fumarate dihydrate - aerosol, metered - 125 mcg/actuation - fluticasone propionate 125 mcg/actuation; formoterol fumarate dihydrate 5 mcg/actuation
flutiform® pressurised inhalation suspension 250 microgram10 microgram per actuation
mundipharma pharmaceuticals pte. ltd. - fluticasone propionate; formoterol fumarate dihydrate - aerosol, metered - 250 mcg/actuation - fluticasone propionate 250 mcg/actuation; formoterol fumarate dihydrate 10 mcg/actuation
flutiform 250 microgram/10 microgram per metered dose pressurised inhalation, suspension
imed healthcare ltd. - fluticasone propionate; formoterol fumarate - pressurised inhalation, suspension - 250/10 µg/µg - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics; formoterol and fluticasone